Stay updated on ELVN-001 for CML Treatment Clinical Trial

Sign up to get notified when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ELVN-001 for CML Treatment Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A consolidated 'Locations' section now includes New York, Oregon, Texas, Ontario, and Jeollabuk-do, and the separate location subsections for these sites were removed. The page revision tag shows Revision: v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:08:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Fadi Haddad, MD as a study contact and removed Koji Sasaki, MD. The page now shows Last Update Posted (Estimated) and revision v3.3.2.
    Difference
    0.2%
    Check dated 2025-11-24T17:07:27.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The government funding lapse notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:02:50.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    No significant changes detected between the screenshots; the study details page appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:30.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Key updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T12:51:27.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Updated page revision to v3.1.0 and added a large set of contact phone numbers; removed an older capitalization variant of a disease term. The main impact is expanded contact information on the page.
    Difference
    0.2%
    Check dated 2025-09-28T09:33:15.000Z thumbnail image

Stay in the know with updates to ELVN-001 for CML Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.